Site Announcement
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
| Date | Form | Description | Docs | XBRL | Pages |
| 03/04/19 | 8-K | Current report filing |
|
201 | |
| 03/04/19 | 425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions |
|
201 | |
| 01/31/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/30/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/30/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/30/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/30/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/30/18 | 8-K | Current report filing |
|
3 | |
| 11/13/18 | DEF 14A | Definitive proxy statements |
|
35 | |
| 11/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
25 |
